A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan High Speed Rail on track to break ridership record this year
12/22/2024 02:37 PM - Sports
Taiwan's Olympic breakdancer places 6th at world championship
12/22/2024 01:04 PM - Society
Taiwan headline news
12/22/2024 12:12 PM - Culture
Taiwanese pop superstar A-Mei sings 1st of 5 concerts at Taipei Dome
12/22/2024 12:07 PM - Society
More cold warnings issued in northern Taiwan as chilly weather lingers
12/22/2024 10:22 AM